Jaguar Health Depreciation & Amortization 2011-2026 | JAGX

Annual Depreciation & Amortization Jaguar Health

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.91 M	1.9 M	2.01 M	1.98 M	1.72 M	1.73 M	1.74 M	1.32 M	584 K	47.5 K	5.16 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.01 M	5.16 K	1.36 M

Quarterly Depreciation & Amortization Jaguar Health

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
468 K	467 K	479 K	461 K	434 K	501 K	489 K	488 K	504 K	-	483 K	422 K	426 K	-	1.29 M	861 K	431 K	-	1.3 M	863 K	432 K	-	1.3 M	873 K	437 K	-	989 K	659 K	330 K	-	296 K	15 K	15 K	-	15 K	9.55 K	7.88 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.3 M	7.88 K	525 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aptorum Group Limited APM	1.13 M	$ 0.89	1.48 %	$ 6.54 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.2	-2.07 %	$ 3.68 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.98	2.41 %	$ 4.91 M	Israel
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.05	-0.98 %	$ 433 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 22.37	-3.95 %	$ 2.85 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.41	-4.73 %	$ 375 M	Britain
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Pharming Group N.V. PHAR	7.28 M	$ 16.36	-0.4 %	$ 7.59 B	Niderland
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands